Celecoxib enhances the response of tumor cells to cisplatin through upregulating PUMA in non–small cell lung cancer carrying wild-type p53
摘要: Celecoxib, a cyclooxygenase-2 inhibitor, can enhance the efficacy of chemotherapy; however, its effect seems inconsistent. In this study,we investigated whether celecoxib would increase the ... ...
(共8頁(yè))
開(kāi)通會(huì)員,享受整站包年服務(wù)